Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nuwiq Extension Study in Severe Hemophilia A
NCT01992549Phase 3Completed
- Sponsor
- Octapharma
- Start
- Apr 2014
- Primary completion
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 9
01
Overview
A Phase 3 trial of simoctocog alfa in hemophilia A, sponsored by Octapharma. Started Apr 2014; status: completed.
02
Drugs
simoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT01992549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01992549.